EVALUATION OF HEALTHCARE COSTS OF ELDERLY NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN VS. RIVAROXABAN AND DABIGATRAN

S. Deitelzweig,X. Luo,K. Gupta,J. Trocio,J. Mardekian, T. Curtice, M. Lingohr-Smith, B. L. Menges,J. Lin

VALUE IN HEALTH(2017)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要